Literature DB >> 24723675

Reversible cerebral vasoconstriction syndrome following indomethacin.

Zeljka Calic1, Ho Choong1, Glen Schlaphoff2, Cecilia Cappelen-Smith3.   

Abstract

BACKGROUND: Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by severe thunderclap headaches and transient segmental cerebral arterial vasoconstriction. Precipitating factors, including the postpartum state and exposure to vasoactive substances are identified in approximately 50% of cases. Non-steroidal anti-inflammatory drugs have rarely been associated with RCVS. CASE DESCRIPTION: We report a case of a 51-year-old female with RCVS after administration of indomethacin given to relieve pain caused by renal colic. Cerebral imaging showed non-aneurysmal cortical subarachnoid hemorrhage, and formal angiography demonstrated widespread multifocal segmental narrowing of medium-sized cerebral arteries. These changes resolved on repeat angiography at 3 weeks. DISCUSSION: Indomethacin is a commonly used drug for treatment of certain primary headache disorders. To date, its mechanism of action remains unclear. A well described side effect of indomethacin is headache, which may be secondary to its vasoconstrictive effects. In our case, we postulate indomethacin, either alone or in combination with emotional stress from pain, triggered or exacerbated an underlying predisposition to RCVS. © International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Thunderclap headache; indomethacin; reversible cerebral vasoconstriction syndrome

Mesh:

Substances:

Year:  2014        PMID: 24723675     DOI: 10.1177/0333102414530526

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  When indomethacin fails: additional treatment options for "indomethacin responsive headaches".

Authors:  Shuhan Zhu; Brian McGeeney
Journal:  Curr Pain Headache Rep       Date:  2015-03

Review 2.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

Review 3.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 4.  Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

5.  Reversible Cerebral Vasoconstriction Syndrome Promptly Diagnosed with Magnetic Resonance Imaging Including Magnetic Resonance Angiography During Immunosuppressive Therapy in a 16-Year-Old Girl with Refractory Cytopenia of Childhood.

Authors:  Hideaki Ueki; Yasushi Sanayama; Akiyo Miyajima; Taichiro Tsuchimochi; Shunji Igarashi; Shosuke Sunami
Journal:  Hematol Rep       Date:  2016-11-17

6.  Reversible cerebral vasoconstriction syndrome at the emergency department.

Authors:  Taerim Kim; Shin Ahn; Chang Hwan Sohn; Dong Woo Seo; Won Young Kim
Journal:  Clin Exp Emerg Med       Date:  2015-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.